RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 55 - per page Next page
Order by
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
These compounds inhibit the deubiquitination of proteins by targeting the deubiquitination enzymes in the protein degradation pathway. More
Monoclonal antibody for a novel HIV protein with potential diagnostic, prognostic, and therapeutic uses. More
Specific and sensitive microarray and multiplex assay for the simultaneous detection and discrimination of HCV, HBV, and HIV-1, which include both RNA and DNA genomes. More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Invention can be developed as an inhibitor therapeutically or prophylactically against retroviral and non-retroviral infections, and can be used in combination with other anti-viral agents to treat patients who have drug-resistant virus. More
Displaying 1..10 of 55 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us